{
    "meta": {
        "found": 1,
        "returned": 1,
        "limit": 10,
        "page": 1
    },
    "data": [
        {
            "uuid": "62ed125b-8686-47c0-bbd8-e2d23e58e82a",
            "title": "EQUITY ALERT: The M&A Class Action Firm Launches Merger Inquiry - VIVO, AERI, CYBE, GMTX",
            "description": "/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the \"M&A Class Action Firm\"), a national...",
            "keywords": "Monteverde & Associates PC",
            "snippet": "NEW YORK, Sept. 24, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the \"M&A Class Actio...",
            "url": "https://www.prnewswire.com:443/news-releases/equity-alert-the-ma-class-action-firm-launches-merger-inquiry--vivo-aeri-cybe-gmtx-301632560.html",
            "image_url": "https://mma.prnewswire.com/media/443626/Monteverde_Associates_PC_Logo.jpg?p=facebook",
            "language": "en",
            "published_at": "2022-09-24T17:00:00.000000Z",
            "source": "prnewswire.com",
            "relevance_score": null,
            "entities": [
                {
                    "symbol": "137310.KS",
                    "name": "SD BioSensor Inc.",
                    "exchange": "KRX",
                    "exchange_long": "Korea Exchange",
                    "country": "kr",
                    "type": "equity",
                    "industry": "Healthcare",
                    "match_score": 47.754417,
                    "sentiment_score": 0.7088,
                    "highlights": [
                        {
                            "highlight": "(VIVO) relating to its proposed acquisition by <em>SD</em> <em>Biosensor</em>, <em>Inc</em>. and SJL Partners LLC. Under the terms of the agreement, VIVO shareholders will receive $34.00 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/meridian-bioscience-inc . It is free and there is no cost or obligation to you.",
                            "sentiment": 0.7579,
                            "highlighted_in": "main_text"
                        },
                        {
                            "highlight": "relating to its proposed acquisition by <em>SD</em> <em>Biosensor</em>, <em>Inc</em>. and SJL Partners LLC. Under the terms of the agreement, VIVO shareholders will receive in cash per share they own. Aerie Pharmaceuticals, Inc. (AERI), relating to its proposed acquisition by Alcon Inc.",
                            "sentiment": 0.6597,
                            "highlighted_in": "main_text"
                        }
                    ]
                }
            ],
            "similar": []
        }
    ]
}
                                    
                                

                                    
                                        {
    "meta": {
        "returned": 1,
        "limit": 10
    },
    "data": [
        {
            "key": "KRX",
            "total_documents": 1,
            "sentiment_avg": 0.7088000178337097
        }
    ]
}